Inventor · San Diego, CA, US

Pingda Ren

138Patents
29h-index
105Co-inventors
93Inventor score

Filing activity: Mar 5, 2004 → Jul 19, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US8193182B2 Substituted isoquinolin-1(2H)-ones, and methods of use thereof Emerging Cross-Sectional Technologies 75 Active
US7745437B2 Compounds and compositions as protein kinase inhibitors Chemistry; Metallurgy 70 Active
US9840516B2 Substituted quinazolines as inhibitors of KRAS G12C Chemistry; Metallurgy 64 Active
US9096611B2 Kinase inhibitors and methods of use Chemistry; Metallurgy 63 Active
US9315505B2 Heterocyclic compounds and uses thereof Chemistry; Metallurgy 63 Active
US9181221B2 Chemical compounds, compositions and methods for kinase modulation Emerging Cross-Sectional Technologies 62 Active
US9359349B2 Substituted quinazolines as kinase inhibitors Emerging Cross-Sectional Technologies 55 Active
US7642255B2 Compounds and compositions as protein kinase inhibitors Chemistry; Metallurgy 53 Active
US8569323B2 Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof Emerging Cross-Sectional Technologies 52 Active
US8604032B2 Chemical compounds, compositions and methods for kinase modulation Emerging Cross-Sectional Technologies 45 Active
US9227978B2 Covalent inhibitors of Kras G12C Physics 45 Active
US9745319B2 Irreversible covalent inhibitors of the GTPase K-Ras G12C Chemistry; Metallurgy 44 Active
US9810690B2 Method for screening inhibitors of Ras Physics 41 Active
US9862701B2 Inhibitors of KRAS G12C mutant proteins Chemistry; Metallurgy 39 Active
US8969363B2 Heterocyclic compounds and uses thereof Chemistry; Metallurgy 38 Active
US8785470B2 Heterocyclic compounds and uses thereof Emerging Cross-Sectional Technologies 38 Active
US9988357B2 Methods for preparation of quinazoline derivatives Chemistry; Metallurgy 38 Active
US8202876B2 Compounds and compositions as protein kinase inhibitors Chemistry; Metallurgy 37 Active
US9926267B2 Covalent inhibitors of K-Ras G12C Physics 37 Active
US8901133B2 Heterocyclic compounds and uses thereof Chemistry; Metallurgy 37 Active
US10144724B2 Substituted quinazoline compounds and methods of use thereof Physics 36 Active
US10111874B2 Combination therapies for treatment of cancer Human Necessities 34 Active
US8703777B2 Certain chemical entities, compositions and methods Emerging Cross-Sectional Technologies 34 Active
US9085560B2 Heterocyclic compounds and uses thereof Emerging Cross-Sectional Technologies 33 Active
US8940742B2 Heterocyclic compounds and uses thereof Emerging Cross-Sectional Technologies 30 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.